ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 135 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 2.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $196,000 | +14.0% | 12,374 | -8.5% | 0.00% | 0.0% |
| Q1 2018 | $172,000 | -25.5% | 13,517 | -32.9% | 0.00% | -50.0% |
| Q4 2017 | $231,000 | +71.1% | 20,132 | +273.3% | 0.00% | +100.0% |
| Q2 2016 | $135,000 | +90.1% | 5,393 | +85.5% | 0.00% | – |
| Q1 2016 | $71,000 | -4.1% | 2,908 | +29.6% | 0.00% | -100.0% |
| Q4 2015 | $74,000 | -21.3% | 2,243 | -21.8% | 0.00% | 0.0% |
| Q3 2015 | $94,000 | +141.0% | 2,870 | +289.9% | 0.00% | – |
| Q2 2015 | $39,000 | – | 736 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 6,402,366 | $128,496,000 | 6.43% |
| Cormorant Asset Management, LP | 150,000 | $3,011,000 | 0.80% |
| PFM Health Sciences, LP | 738,027 | $14,812,000 | 0.30% |
| Partner Investment Management, L.P. | 27,893 | $560,000 | 0.11% |
| Spark Investment Management LLC | 32,100 | $642,000 | 0.10% |
| PointState Capital LP | 275,000 | $5,519,000 | 0.07% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 97,809 | $1,963,000 | 0.06% |
| CADIAN CAPITAL MANAGEMENT, LP | 100,000 | $2,007,000 | 0.06% |
| Nicholas Investment Partners, LP | 50,456 | $1,013,000 | 0.06% |
| Baker Brothers Advisors | 153,350 | $3,078,000 | 0.04% |